This event has completed.

3/15/2024
12:00 PM - 2:00 PM EST

This presentation will review the significance of chronic insomnia disorder and highlight best practices for both the assessment and management of patients with chronic insomnia disorder.

Todd Arnedt is a Professor of Psychiatry and Neurology, Director of the Behavioral Sleep Medicine Program, and Co-Director of the Sleep and Circadian Research Laboratory at Michigan Medicine. Dr. Arnedt is a clinical psychologist who sees patients with sleep disorders including insomnia, circadian rhythm sleep–wake disorders, sleep apnea, and parasomnias. As Director of the Behavioral Sleep Medicine Program and Associate Director of the Sleep Disorders Fellowship, he is actively involved in training the next generation of sleep and circadian clinicians and researchers. Dr. Arnedt’s research focuses on sleep and circadian rhythms in mental health disorders, with a specific focus on substance use disorders. He has received funding from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). He serves on the editorial boards for Behavioral Sleep Medicine, SLEEP, SLEEP Advances, Current Sleep Medicine Reports, and Frontiers in Sleep and has been in leadership roles for the American Academy of Sleep Medicine and Sleep Research Society.

At the end of this lecture, participants should be able to answer:

1. What are the primary consequences of untreated chronic insomnia disorder?
2. What are key assessment tools in the assessment of chronic insomnia disorder?
3. What are the main advantages and disadvantages of medication treatments for insomnia?
4. What are the main advantages and disadvantages of psychological treatments for insomnia?